Gal Pim, Smit Jaap Jan J, Adiyaman Ahmet, Ramdat Misier Anand R, Delnoy Peter Paul H M, Elvan Arif
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands.
Int J Cardiol Heart Vasc. 2015 May 23;8:68-72. doi: 10.1016/j.ijcha.2015.05.005. eCollection 2015 Sep 1.
Pulmonary vein isolation (PVI) for atrial fibrillation (AF) is performed with the endoscopically assisted laser balloon ablation system (EAS). We hypothesized that placement of a circular mapping catheter (CMC) in the pulmonary vein (PV) distal to the laser balloon during ablation is feasible and safe.
Out of 58 included patients, 37 underwent mapping-guided EAS PVI, with the CMC inside the PV during laser ablation, and 21 patients underwent standard EAS PVI, with the CMC outside the PV during laser ablation.
Mean age was 56 years and 81% had paroxysmal AF. In the mapping-guided ablation group, 91% of PVs were isolated with the CMC in the PV during EAS ablation, isolation was completed in 9% of PVs after the CMC was removed from the PV. After passing a learning curve in 18 patients, a significant drop in unsuccessfully isolated PVs was observed in the mapping guided EAS PVI group (15% to 4%, = 0.020). No major complications were seen in the mapping-guided EAS PVI group. However, in the standard EAS PVI group, laser ablation was complicated by a temporary phrenic nerve palsy in 1 patient. After a median follow-up of 16.7 months, there was no statistical difference in AF free survival among treatment groups (mapping-guided: 56% vs. 52%, = 0.875).
Mapping guided EAS PVI with a distal CMC in the PV during laser ablation is feasible and seems safe as the standard EAS PVI approach.
采用内镜辅助激光球囊消融系统(EAS)进行心房颤动(AF)的肺静脉隔离(PVI)。我们假设在消融过程中将环形标测导管(CMC)置于激光球囊远端的肺静脉(PV)内是可行且安全的。
在纳入的58例患者中,37例接受标测引导下的EAS PVI,激光消融时CMC置于PV内,21例患者接受标准EAS PVI,激光消融时CMC置于PV外。
平均年龄为56岁,81%患有阵发性AF。在标测引导消融组中,91%的PV在EAS消融时通过置于PV内的CMC实现隔离,在CMC从PV取出后,9%的PV完成隔离。在18例患者度过学习曲线后,标测引导EAS PVI组中未成功隔离的PV显著减少(从15%降至4%,P = 0.020)。标测引导EAS PVI组未出现重大并发症。然而,在标准EAS PVI组中,1例患者激光消融出现暂时性膈神经麻痹并发症。中位随访16.7个月后,各治疗组之间无房颤无复发生存率的统计学差异(标测引导组:56% vs. 52%,P = 0.875)。
激光消融时在PV内使用远端CMC进行标测引导的EAS PVI是可行的,并且似乎与标准EAS PVI方法一样安全。